CCS
Century Communities, Inc.
CCS trails on the overall score without a compensating advantage in the available component scores.
NKE
NIKE, Inc.
NKE has the edge over CCS overall, supported by stronger valuation and lower modeled downside.
CCS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Stable |
CCS's profitability and balance sheet are currently stable, but its revenue and cash flow are under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.2x | $15.75 | -70% |
| Fair | 8x | $29.98 | -42% |
| Expensive | 11x | $39.91 | -23% |
| Current | 14x | $51.92 | — |
| Forward | 27x | $51.92 | — |
Historical ranges are pointers, not guarantees.
CCS's PE is in its expensive range at 14x. Analysts expect earnings to fall, which would put today's price at 27x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over CCS in the historical PE scenario, which offers more potential upside but is not a forecast.
CCS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CCS's earnings and profitability to decline, with its revenue holding steady.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.89 | -50% |
| Q3 2026 | $3.75 | -45% |
| Q2 2026 | $4.56 | -44% |
| Q1 2026 | $4.44 | -54% |
| Q4 2025 | $4.86 | -53% |
| Q3 2025 | $6.85 | -32% |
| Q2 2025 | $8.19 | -18% |
| Q1 2025 | $9.66 | +7.2% |
| Q4 2024 | $10.40 | +29% |
CCS's earnings per share have fallen from their peak: $3.75 over the past year, against $18.20 in late 2022.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $864.5M | -12% |
| Q2 2026 | $927.2M | -7.3% |
| Q1 2026 | $789.7M | -13% |
| Q4 2025 | $1.2B | -3.1% |
| Q3 2025 | $980.3M | -14% |
| Q2 2025 | $1B | -3.7% |
| Q1 2025 | $903.2M | -4.8% |
| Q4 2024 | $1.3B | +5.6% |
CCS's revenue has slid since its 2024 peak: $864M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | -3 points |
| Q2 2026 | 5.3% | +0.6 points |
| Q1 2026 | 4.2% | -1.6 points |
| Q4 2025 | 3.8% | -6.8 points |
| Q3 2025 | 4.9% | -4.8 points |
| Q2 2025 | 4.7% | -5.9 points |
| Q1 2025 | 5.8% | -3.1 points |
| Q4 2024 | 11% | +0.2 points |
CCS's operating margin was 1.8% last quarter, down 3 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over CCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over CCS on profitability, with a higher operating margin.
CCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$142.4M | -$121.6M |
| Q2 2026 | -$89.6M | -$72.1M |
| Q1 2026 | -$57.1M | -$17.1M |
| Q4 2025 | $202.6M | -30% |
| Q3 2025 | -$20.8M | +$81.1M |
| Q2 2025 | -$17.6M | +$100.1M |
| Q1 2025 | -$40M | -355% |
| Q4 2024 | $290.6M | +$310.6M |
CCS has burned cash in six of the last eight quarters: −$87M over the past year, against $212M the year before.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over CCS on cash generation, producing positive trailing cash flow while its opponent burns cash.
CCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -177K shares |
| 1 year | -5.1% | -1.5M shares |
| 3 years | -12% | -3.8M shares |
| 5 years | -17% | -6M shares |
| Available history | -8.7% | -2.7M shares |
CCS has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11.6M |
| Q2 2026 | $19.6M |
| Q1 2026 | $40M |
| Q4 2025 | $20M |
| Q3 2025 | $20M |
| Q2 2025 | $48M |
| Q1 2025 | $55.6M |
| Q4 2024 | $30.7M |
CCS spent $91M buying back its own shares over the past year, down 41% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | -0.0x | Net Cash |
CCS's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over CCS on leverage, with a lower net debt burden relative to earnings.
CCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 12.1 | Oversold |
CCS's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CCS PE vs Consumer Cyclical Sector
| Metric | CCS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 23% below |
| PE % | 95 | 47 | 48 pts above |
CCS has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.3 | 7.8% below |
| 20 week MA | $62.7 | 17% below |
| 50 week MA | $61.8 | 16% below |
| 100 week MA | $62.7 | 17% below |
| 200 week MA | $70.9 | 27% below |
CCS is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over CCS on trend strength, trading above more of its moving averages.
CCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $47.5 | +74% |
| 2021 | $47.5 | $79.5 | +67% |
| 2022 | $79.5 | $51.4 | -35% |
| 2023 | $51.4 | $91.1 | +77% |
| 2024 | $91.1 | $73.6 | -19% |
| 2025 | $73.6 | $59.0 | -20% |
| 2026 YTD | $59.0 | $51.9 | -12% |
CCS has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.